The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic Treatment by Nina J. Wesdorp, MD, Karen Bolhuis, MD, Joran Roor, MSc, Jan-Hein T. M. van Waesberghe, MD, PhD, Susan van Dieren, MSc, PhD, Martin J. van Amerongen, MD, PhD, Thiery Chapelle, MD, PhD, Cornelis H. C. Dejong, MD, PhD, Marc R. W. Engelbrecht, MD, PhD, Michael F. Gerhards, MD, PhD, Dirk Grunhagen, MD, PhD, Thomas M. van Gulik, MD, PhD, John J. Hermans, MSc, MD, PhD, Koert P. de Jong, MD, PhD, Joost M. Klaase, MD, PhD, Mike S. L. Liem, MD, PhD, Krijn P. van Lienden, MD, PhD, I. Quintus Molenaar, MD, PhD, Gijs A. Patijn, MD, PhD, Arjen M. Rijken, MD, PhD, Theo M. Ruers, MD, PhD, Cornelis Verhoef, MD, PhD, Johannes H. W. de Wilt, MD, PhD, Rutger-Jan Swijnenburg, MD, PhD, Cornelis J. A. Punt, MD, PhD, Joost Huiskens, MD, PhD, Geert Kazemier, MD, PhD, for the Dutch Colorectal Cancer Group Liver Expert Panel

Get full text